Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Tongxin dropping pills for myocardial perfusion after primary PCI in acute ST-elevation myocardial infarction
ChiCTR-IPC-17010823Phase 4Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Shexiang Tongxin dropping pills with Placebo (2 arms). Primary endpoints: Corrected TIMI frame count and One-year major adverse cardiac events. Started Mar 2017; status: recruiting.
02
Drugs
Shexiang Tongxin Dropping Pills
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-IPC-17010823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-17010823.